Equities Research Analysts’ New Coverage for September 21st (AIP, AON, CRWV, IMNM, NBIS, NNE, NXE, ODD, SECZ, VRTX)

Equities Research Analysts’ new coverage for Monday, September 21st:

Craig Hallum began coverage on shares of Arteris (NASDAQ:AIP). Craig Hallum issued a buy rating and a $30.00 price target on the stock.

Citigroup Inc. initiated coverage on shares of AON (NYSE:AON). Citigroup Inc. issued a buy rating and a $435.00 price target on the stock.

Rothschild & Co Redburn began coverage on shares of CoreWeave (NASDAQ:CRWV). Rothschild & Co Redburn issued a sell rating and a $54.00 price target on the stock.

Alliance Global Partners started coverage on shares of Immunome (NASDAQ:IMNM). Alliance Global Partners issued a buy rating and a $32.00 target price on the stock.

Rothschild & Co Redburn assumed coverage on shares of Nebius Group (NASDAQ:NBIS). Rothschild & Co Redburn issued a sell rating and a $84.00 target price on the stock.

Needham & Company LLC started coverage on shares of Nano Nuclear Energy (NASDAQ:NNE). Needham & Company LLC issued a buy rating and a $33.00 price target on the stock.

JPMorgan Chase & Co. began coverage on shares of NexGen Energy (NYSE:NXE). The firm issued an overweight rating and a $14.00 price target on the stock.

JPMorgan Chase & Co. assumed coverage on shares of ODDITY Tech (NASDAQ:ODD). JPMorgan Chase & Co. issued a neutral rating and a $18.00 target price on the stock.

Cantor Fitzgerald assumed coverage on shares of Securitize (NYSE:SECZ). They issued an overweight rating and a $21.20 price target on the stock.

Leerink Partners assumed coverage on shares of Vertex Pharmaceuticals (NASDAQ:VRTX). The firm issued an outperform rating and a $594.00 price target on the stock.

Cantor Fitzgerald started coverage on shares of Global Medical REIT (NYSE:XRN). They issued an overweight rating and a $43.00 price target on the stock.